Literature DB >> 31472888

Hypertension and Heart Failure.

Jeremy Slivnick1, Brent C Lampert2.   

Abstract

Hypertensive heart disease represents a spectrum of illnesses from uncontrolled hypertension to heart failure. The authors discuss the natural history and pathogenesis of heart failure owing to hypertensive heart disease, reviewing the important role of left ventricular hypertrophy as the inciting process leading to diastolic dysfunction and heart failure with preserved ejection fraction. They describe the various mechanisms by which a subset of patients ultimately develops systolic heart failure. They discuss management strategies for hypertensive heart disease at all stages of the disease process. Treatment in the initial stages before onset of heart failure may result in regression of disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HFpEF; HFrEF; Heart failure; Heart failure drug therapy; Hypertension; LVH

Year:  2019        PMID: 31472888     DOI: 10.1016/j.hfc.2019.06.007

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  30 in total

1.  Cardiac disorders worsen the final outcome in myasthenic crisis undergoing non-invasive mechanical ventilation: a retrospective 20-year study from a single center.

Authors:  Erika Iori; Alessandra Ariatti; Marco Mazzoli; Elisabetta Bastia; Manuela Gozzi; Virginia Agnoletto; Alessandro Marchioni; Giuliana Galassi
Journal:  Acta Myol       Date:  2022-03-31

Review 2.  The role of the gut microbiota in health and cardiovascular diseases.

Authors:  Lu Wang; Shiqi Wang; Qing Zhang; Chengqi He; Chenying Fu; Quan Wei
Journal:  Mol Biomed       Date:  2022-10-11

3.  [A nomogram based on systemic inflammation markers can predict adverse outcomes in patients with heart failure].

Authors:  Z Liu; X Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-08-20

4.  Assessing Causal Associations of Atopic Dermatitis With Heart Failure and Other Cardiovascular Outcomes: A Mendelian Randomization Study.

Authors:  Heng Chen; Chengui Zhuo; Liangrong Zheng
Journal:  Front Cardiovasc Med       Date:  2022-06-15

Review 5.  Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.

Authors:  Danni Mu; Jin Cheng; Ling Qiu; Xinqi Cheng
Journal:  Front Cardiovasc Med       Date:  2022-07-04

6.  Zi Shen Huo Luo Formula Enhances the Therapeutic Effects of Angiotensin-Converting Enzyme Inhibitors on Hypertensive Left Ventricular Hypertrophy by Interfering With Aldosterone Breakthrough and Affecting Caveolin-1/Mineralocorticoid Receptor Colocalization and Downstream Extracellular Signal-Regulated Kinase Signaling.

Authors:  Xiaotong Song; Yue Zhao; Shijun Wang; Yuan Wang; Qian Chen; Haijun Zhao; Hua Wang; Sheng Tian; Huayun Yu; Zhichun Wu
Journal:  Front Pharmacol       Date:  2020-04-03       Impact factor: 5.810

Review 7.  The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions.

Authors:  Daniela Sorriento; Maria Rosaria Rusciano; Valeria Visco; Antonella Fiordelisi; Federica Andrea Cerasuolo; Paolo Poggio; Michele Ciccarelli; Guido Iaccarino
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

Review 8.  Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging.

Authors:  Sherin Saheera; Prasanna Krishnamurthy
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

9.  Nursing case management for people with hypertension: A randomized controlled trial protocol.

Authors:  Chunjing Song; Xianhong Li; Xueling Ning; Shiqiang Song
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

Review 10.  Potential Applications and Functional Roles of Exosomes in Cardiometabolic Disease.

Authors:  Sergio Ayala-Mar; Belén Rodríguez-Morales; Pedro Chacón-Ponce; José González-Valdez
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.